During the past decade, Angelique Barreto, MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Angelique Barreto, MD" are "Diabetic Neuropathy, Painful" (1 trials), "Epilepsies, Partial" (1 trials) and "Partial Seizures" (1 trials). Many other conditions were trialed in "Angelique Barreto, MD" in a lesser frequency.

Most popular intervention types in "Angelique Barreto, MD" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "placebo" (1 trials), "pregabalin" (1 trials) and "pregabalin (Lyrica)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Angelique Barreto, MD" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Angelique Barreto, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Angelique Barreto, MD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Angelique Barreto, MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".